APA

Liu Q., Lu K., Zhu H., Kong S., Yuan J., Zhang G., Chen N., Gu C., Pan C., Mo D. & Su G. (20190321). Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. : European journal of medicinal chemistry.

Chicago

Liu Qing-Qing, Lu Ke, Zhu Hai-Miao, Kong Shi-Lin, Yuan Jing-Mei, Zhang Guo-Hai, Chen Nan-Ying, Gu Chen-Xi, Pan Cheng-Xue, Mo Dong-Liang and Su Gui-Fa. 20190321. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. : European journal of medicinal chemistry.

Harvard

Liu Q., Lu K., Zhu H., Kong S., Yuan J., Zhang G., Chen N., Gu C., Pan C., Mo D. and Su G. (20190321). Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. : European journal of medicinal chemistry.

MLA

Liu Qing-Qing, Lu Ke, Zhu Hai-Miao, Kong Shi-Lin, Yuan Jing-Mei, Zhang Guo-Hai, Chen Nan-Ying, Gu Chen-Xi, Pan Cheng-Xue, Mo Dong-Liang and Su Gui-Fa. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. : European journal of medicinal chemistry. 20190321.